Recent work has identified a DC-intrinsic immunoregulatory circuit in which β-catenin activation in DCs-particularly in cross-presenting cDC1s-induces expression of TIM-3, thereby suppressing CD8 T cell cross-priming and limiting anti-tumor CD8 T cell immunity. Here, CD8A is linked to neoplasm.